$23.59
0.190.81%
近くで: Nov 19, 4:00 PM EST
$23.59
N/A
時間外: 4:00 PM EST

The average analyst price target for Rapport Therapeutics is $56.71, 140.4% above the current price. Of 14 analysts, 14 rate it Buy. Targets range from $28 to $89. The latest change came on Nov 5, 2026, when UBS lowered its price target on Rapport Therapeutics from $71 to $64 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months